EDGAR Filing Documents for 0001193125-17-365072

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-17-365072

Filing Date

2017-12-08

Accepted

2017-12-11 08:15:31

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	REGISTRATION STATEMENT ON FORM S-3	d481260ds3.htm	S-3	312037
2	EX-4.3	d481260dex43.htm	EX-4.3	309296
3	EX-4.5	d481260dex45.htm	EX-4.5	107564
4	EX-4.6	d481260dex46.htm	EX-4.6	108917
5	EX-4.7	d481260dex47.htm	EX-4.7	100047
6	EX-5.1	d481260dex51.htm	EX-5.1	23076
7	EX-12.1	d481260dex121.htm	EX-12.1	10746
8	EX-23.1	d481260dex231.htm	EX-23.1	1768
9	GRAPHIC	g481260g08c20.jpg	GRAPHIC	36896
10	GRAPHIC	g481260g17c79.jpg	GRAPHIC	28507
	Complete submission text file	0001193125-17-365072.txt		1064750

Mailing Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306

Business Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306 650-279-9845

Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-221972 | Film No.: 171248476
SIC: 2836 Biological Products, (No Diagnostic Substances)